Equatorial Guinea vs Moldova: Average cost of drugs for extensively drug-resistant tuberculosis
Equatorial Guinea
1,500 constant 2022 US$
in 2024
Moldova
1,400 constant 2022 US$
in 2024
Equatorial Guinea rank
33rd
Moldova rank
36th
Average cost of drugs for extensively drug-resistant tuberculosis over time
- Equatorial Guinea
- Moldova
How they compare
Equatorial Guinea currently reports 1,500 constant 2022 US$ against 1,400 constant 2022 US$ in Moldova, a difference of 100 constant 2022 US$.
That makes Equatorial Guinea's figure about 1.1 times Moldova's.
The two have swapped places 2 times across 6 shared years of data; in 2019 it was Equatorial Guinea ahead.
Equatorial Guinea ranks 33rd and Moldova ranks 36th of 56 countries.
Across the 2 decades both report, Equatorial Guinea averaged higher in 1 and Moldova in 1.
Head to head by decade
| Decade | Equatorial Guinea | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4,000 constant 2022 US$ | 2,911 constant 2022 US$ | 1,089 constant 2022 US$ | Equatorial Guinea |
| 2020s | 2,301 constant 2022 US$ | 2,970 constant 2022 US$ | 668.6 constant 2022 US$ | Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of drugs for extensively drug-resistant tuberculosis, Equatorial Guinea or Moldova?
- Equatorial Guinea, at 1,500 constant 2022 US$ against 1,400 constant 2022 US$ in Moldova as of 2024.
- What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between Equatorial Guinea and Moldova?
- 100 constant 2022 US$, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Moldova?
- 6 years are reported by both, from 2019 to 2024.
- How do Equatorial Guinea and Moldova rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
- Equatorial Guinea ranks 33rd and Moldova ranks 36th of 56 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.